A Systematic Review on Extracellular Vesicles-Enriched Fat Grafting: A Shifting Paradigm. (15th December 2020)

• Record Type: Journal Article
• Authors: Ghiasloo, Mohammad; De Wilde, Laura; Singh, Kashika; Tonnard, Patrick; Verpaele, Alexis; De Wever, Olivier; Blondeel, Phillip
• Is Part Of: Aesthetic surgery journal. Volume 41:Number 11(2021)
• Page Start: NP1695
• Page End: NP1705
• Publication Date: 2020-12-15
• Subjects: Surgery, Plastic -- Periodicals; 617.95
• DOI: 10.1093/asj/sjaa362
• Languages: English
• ISSNs: 1090-820X

Abstract

Abstract: Background: Recent evidence confirms that mesenchymal stem cells (MSCs) facilitate angiogenesis mainly through paracrine function. Extracellular vesicles (EVs) are regarded as key components of the cell secretome, possessing functional properties of their source cells. Subsequently, MSC-EVs have emerged as a novel cell-free approach to improve fat graft retention rate. Objectives: The authors sought to provide a systematic review of all studies reporting the utilization of MSC-EVs to improve graft retention rate. Methods: A systematic search was undertaken employing the Embase, PubMed, and Cochrane Central Register of Controlled Trials databases. Outcome measures included donor/receptor organism of the fat graft, study model, intervention groups, evaluation intervals, EV research data, and in vitro and in vivo results. Results: Of the total 1717 articles, 62 full texts were screened. Seven studies reporting on 294 mice were included. Overall, EV-treated groups showed higher graft retention rates compared with untreated groups. Notably, retention rate was similar following EV and MSC treatment. In addition to reduced inflammation, graft enrichment with EVs resulted in early revascularization and better graft integrity. Interestingly, hypoxic preconditioning of MSCs improved their beneficial paracrine effects and led to a more proangiogenic EV population, as observed by both in vitro and in vivo results. Conclusions: MSC-EVs appear to offer an interesting cell-free alternative to improve fat graft survival. Although their clinical relevance remains to be determined, it is clear that not the cells but rather their secretome is essential for graft survival. Thus, a paradigm shift from cell-assisted lipotransfer towards "secretome-assisted lipotransfer" is well on its way. Level of Evidence: 4: